Position in CYCN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1
+$0 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYCN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,846,799 across 523 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in CYCN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1 | 1 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1 | 1 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $1,492 | 649 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $1,888 | 649 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $1,622 | 649 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,089 | 649 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,680 | 649 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,492 | 649 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $2,076 | 649 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $2,338 | 698 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $2,813 | 823 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $3,389 | 823 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,224 | 12,040 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,156 | 3,289 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,920 | 3,398 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,881 | 5,251 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $43,494 | 39,185 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $125,326 | 72,865 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $228,738 | 74,508 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $273,603 | 70,155 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $105,406 | 37,781 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,264,256 | 413,156 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $379,172 | 62,364 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $47,739 | 8,078 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,369 | 2,781 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||